Male Breast Cancer Completed Phase 1 Trials for Decitabine (DB01262)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00030615Decitabine in Treating Patients With Advanced Solid TumorsTreatment